https://hemoshear.comhttps://hemoshear.com/companyhttps://hemoshear.com/pipelinehttps://hemoshear.com/platformhttps://hemoshear.com/newshttps://hemoshear.com/careershttps://hemoshear.com/news/hemoshear-therapeutics-participates-in-piper-sandler-symposiumhttps://hemoshear.com/news/shear-insights-from-crisis-to-opportunity-hemoshear-continues-to-obtain-tissue-to-advance-researchhttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-attends-family-and-scientific-meetingshttps://hemoshear.com/news/shear-insights-medical-journal-publishes-hemoshear-pilothttps://hemoshear.com/news/shear-insights-parents-share-their-childrens-journey-with-methylmalonic-acidemiahttps://hemoshear.com/news/hemoshear-therapeutics-to-participate-in-piper-sandler-healthcare-conferencehttps://hemoshear.com/news/hemoshear-therapeutics-to-participate-in-svb-leerink-securities-biopharma-private-company-connecthttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-has-built-a-world-class-drug-discovery-organization-to-advance-its-rare-disease-portfoliohttps://hemoshear.com/news/hemoshear-therapeutics-advancing-novel-modulators-against-second-target-for-horizon-therapeutics-gout-discovery-pipelinehttps://hemoshear.com/news/hemoshear-therapeutics-appoints-brian-wamhoff-phd-interim-chief-executive-officerhttps://hemoshear.com/news/hemoshear-develops-new-human-tissue-based-model-of-rare-liver-disease-under-research-collaboration-with-takedahttps://hemoshear.com/news/the-jump-study-posterhttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-presents-pilot-data-from-mma-and-pa-natural-history-studyhttps://hemoshear.com/news/the-jump-studyhttps://hemoshear.com/news/hemoshear-therapeutics-appoints-patrick-horn-md-phd-chief-medical-officerhttps://hemoshear.com/news/shear-insights-hemoshear-to-be-featured-at-international-metabolic-conferencehttps://hemoshear.com/news/hemoshear-identifies-second-target-to-treat-nash-for-takedahttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-appoints-organizational-development-leader-and-recruiter-as-company-growshttps://hemoshear.com/news/shear-insights-susan-klees-appointed-by-governor-to-virginias-newly-established-rare-disease-councilhttps://hemoshear.com/news/hemoshear-therapeutics-advancing-several-novel-compounds-for-horizon-therapeutics-plc-gout-discovery-pipelinehttps://hemoshear.com/news/shear-insights-brian-wamhoff-recognized-as-one-of-the-pharmavoice-100-most-inspiring-peoplehttps://hemoshear.com/news/hemoshear-therapeutics-announces-first-two-patients-dosed-in-phase-2-study-of-oral-small-molecule-hst5040-for-methylmalonic-acidemia-mma-and-propionic-acidemia-pahttps://hemoshear.com/news/shear-insights-peer-reviewed-journal-publishes-the-discovery-of-hemoshears-hst5040-small-molecule-in-clinical-development-for-methylmalonic-acidemia-mma-and-propionic-acidemia-pahttps://hemoshear.com/news/hemoshear-therapeutics-advances-second-novel-drug-target-into-horizon-therapeutics-plc-early-discovery-pipeline-for-gouthttps://hemoshear.com/news/molecular-genetics-and-metabolism-publishes-primary-pharmacology-data-supporting-hemoshears-hst5040-as-a-potential-treatment-for-methylmalonic-acidemia-mma-and-propionic-acidemia-pahttps://hemoshear.com/news/biocentury-40m-series-a-sets-up-hemoshear-to-complete-evolution-from-service-play-to-clinical-stage-biotech-https://hemoshear.com/news/hemoshear-therapeutics-raises-40-million-in-series-a-financing-to-advance-rare-disease-portfoliohttps://hemoshear.com/news/hemoshear-announces-appointment-of-vice-presidentshttps://hemoshear.com/news/hemoshear-therapeutics-hst5040-receives-us-orphan-drug-designations-for-treatment-of-methylmalonic-acidemia-and-propionic-acidemiahttps://hemoshear.com/news/hemoshear-therapeutics-identifies-novel-drug-target-to-treat-nash-in-drug-discovery-partnership-with-takedahttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-to-present-at-piper-sandler-annual-healthcare-conferencehttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-launches-pilot-study-to-evaluate-neuropsychological-assessments-for-mma-and-pahttps://hemoshear.com/news/hemoshear-therapeutics-enters-into-rare-liver-disease-research-collaboration-with-takedahttps://hemoshear.com/news/shear-insights-mavis-waller-appointed-to-vice-president-clinical-operations-as-hemoshear-readies-for-clinical-trialshttps://hemoshear.com/news/hemoshear-therapeutics-featured-as-nih-small-business-innovation-research-grant-success-storyhttps://hemoshear.com/news/hemoshear-to-present-at-upcoming-investor-conferenceshttps://hemoshear.com/news/hemoshear-therapeutics-receives-fda-fast-track-and-rare-pediatric-disease-designations-for-hst5040-to-treat-methylmalonic-acidemia-and-propionic-acidemiahttps://hemoshear.com/news/hemoshear-therapeutics-achieves-milestone-in-exclusive-drug-discovery-collaboration-with-horizon-therapeutics-in-gouthttps://hemoshear.com/news/hemoshear-therapeutics-receives-fda-clearance-of-ind-for-phase-2-study-of-its-investigational-drug-hst5040-for-the-treatment-of-methylmalonic-acidemia-and-propionic-acidemiahttps://hemoshear.com/news/shear-insights-journal-publishes-hemoshear-models-for-rare-metabolic-diseaseshttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-engages-with-european-metabolic-disease-consortiumhttps://hemoshear.com/news/hemoshear-therapeutics-appoints-brian-a-johns-phd-chief-scientific-officerhttps://hemoshear.com/news/prestigious-journal-publishes-hemoshear-research-on-gene-expression-and-liver-diseasehttps://hemoshear.com/news/takeda-and-hemoshear-therapeutics-the-nash-collaborationhttps://hemoshear.com/news/hemoshear-therapeutics-to-present-at-wedbush-pacgrow-healthcare-conferencehttps://hemoshear.com/news/hemoshear-therapeutics-names-biopharma-veteran-kathleen-m-metters-phd-to-board-of-directorshttps://hemoshear.com/news/qa-on-hemoshears-3d-model-of-the-tumor-microenvironmenthttps://hemoshear.com/news/takeda-and-hemoshear-therapeutics-extend-exclusive-drug-discovery-partnership-in-liver-diseaseshttps://hemoshear.com/news/hemoshear-therapeutics-physiological-human-tumor-model-published-in-lab-on-a-chip-journalhttps://hemoshear.com/news/horizon-pharma-plc-and-hemoshear-therapeutics-enter-into-exclusive-drug-discovery-collaboration-in-gouthttps://hemoshear.com/news/carnot-biosciences-a-spin-off-of-smartzyme-biopharma-and-hemoshear-therapeutics-partner-to-develope-protein-based-therapeutics-for-rare-metabolic-diseaseshttps://hemoshear.com/news/shear-insights-hemoshear-identifies-novel-targets-for-treating-liver-diseaseshttps://hemoshear.com/news/shear-insights-hemoshear-invited-to-share-expertise-at-3d-modeling-conferencehttps://hemoshear.com/news/shear-insights-hemoshear-therapeutics-continues-to-engage-with-rare-disease-groupshttps://hemoshear.com/news/hemoshear-technology-utilized-to-create-3d-model-of-cancer-tumorshttps://hemoshear.com/news/pioneering-new-3d-cancer-model-to-speed-new-treatmentshttps://hemoshear.com/news/qa-with-brian-wamhoff-phd-head-of-innovation-hemoshear-therapeuticshttps://hemoshear.com/news/uva-biomedical-engineering-student-gains-real-work-experience-at-hemoshearhttps://hemoshear.com/news/hemoshears-maple-syrup-urine-disease-model-presented-at-society-for-inherited-metabolic-disorders-meetinghttps://hemoshear.com/news/hemoshear-therapeutics-and-childrens-national-rare-disease-institute-to-present-data-on-four-research-programs-in-childrens-rare-diseases-at-the-society-for-inherited-metabolic-disorders-meetinghttps://hemoshear.com/news/shear-insights-new-york-academy-of-science-features-hemoshear-platform-for-liver-diseaseshttps://hemoshear.com/news/takeda-and-hemoshear-therapeutics-enter-into-exclusive-drug-discovery-partnership-in-liver-diseaseshttps://hemoshear.com/news/hemoshear-therapeutics-receives-governor-mcauliffes-2017-virginia-science-innovation-awardhttps://hemoshear.com/news/biopharmas-welcome-research-grant-funding-renewalhttps://hemoshear.com/news/hemoshear-therapeutics-appoints-john-e-reardon-as-head-of-research-and-developmenthttps://hemoshear.com/news/hemoshear-therapeutics-publishes-data-in-journal-of-clinical-investigation-insight-on-its-model-of-non-alcoholic-steatohepatitis-nashhttps://hemoshear.com/news/hemoshear-therapeutics-to-present-data-from-its-drug-discovery-platform-for-nash-at-the-american-association-for-the-study-of-liver-diseases-annual-meetinghttps://hemoshear.com/news/uva-health-system-and-hemoshear-therapeutics-to-collaborate-on-advanced-cancer-tumor-modelshttps://hemoshear.com/news/hemoshears-head-of-innovation-awarded-as-local-entrepreneur-of-yearhttps://hemoshear.com/news/organic-acidemia-association-announces-funding-support-to-develop-natural-history-studies-of-diseaseshttps://hemoshear.com/news/npr-biotech-nation-radio-science-and-technology-collaboratehttps://hemoshear.com/news/hemoshear-therapeutics-announces-next-stage-of-safety-collaboration-with-pfizer-inchttps://hemoshear.com/news/hemoshear-therapeutics-races-toward-discovery-of-treatments-for-childrens-rare-diseaseshttps://hemoshear.com/news/hemoshear-therapeutics-and-childrens-national-medical-center-co-present-in-the-middle-east-on-rare-metabolic-disordershttps://hemoshear.com/news/hemoshear-therapeutics-names-h-thomas-watkins-to-board-of-directorshttps://hemoshear.com/news/hemoshear-therapeutics-llc-to-present-data-on-its-drug-discovery-platform-at-the-american-association-for-the-study-of-liver-diseaseshttps://hemoshear.com/news/tedx-charlottesville-hemoshear-and-childrens-present-saving-a-child-with-a-rare-diseasehttps://hemoshear.com/news/hemoshear-therapeutics-names-robert-gould-to-board-of-directorshttps://hemoshear.com/news/hemoshear-expands-focus-to-discovery-of-therapeuticshttps://hemoshear.com/news/hemoshear-announces-collaboration-with-pfizer-inc-to-help-identify-and-predict-drug-induced-vascular-injury-for-early-stage-compoundshttps://hemoshear.com/news/toward-better-understanding-of-human-drug-responsehttps://hemoshear.com/news/hemoshear-and-childrens-national-health-system-to-unveil-new-paradigm-for-accelerating-rare-disease-drug-discoveryhttps://hemoshear.com/news/nprs-tech-nation-studying-human-diseasehttps://hemoshear.com/news/hemoshear-wins-a-national-2014-tibbetts-sbir-award-from-the-small-business-administrationhttps://hemoshear.com/news/high-tech-small-businesses-receive-tibbetts-award-for-innovative-and-outstanding-contributions